The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Renal Dialysis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Renal Dialysis


Psychiatry related information on Renal Dialysis


High impact information on Renal Dialysis


Chemical compound and disease context of Renal Dialysis


Biological context of Renal Dialysis


Anatomical context of Renal Dialysis


Associations of Renal Dialysis with chemical compounds

  • Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent [29].
  • The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis [30].
  • In another group of diabetic patients the mean serum creatinine level, which decreased by 75 percent during a session of hemodialysis, whereas the level of AGE peptides decreased by only 24 percent [31].
  • We determined serum high-density lipoprotein cholesterol content and analyzed the approtein structure of the various lipoprotein fractions in 21 patients on chronic hemodialysis [32].
  • Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding [33].

Gene context of Renal Dialysis

  • The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients [34].
  • Our data support a pathogenic link among activated inflammatory response, endothelial injury, and CAD in hemodialysis patients and suggest that assessment of circulating PAI-1 levels could be an additional tool to identify dialysis patients who are at risk for developing atheromatous cardiovascular disease [35].
  • Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes [36].
  • Circulating CD34+ cells (1 x 10(4)) were isolated from rHuEPO hyporesponsive hemodialysis patients (EPO-H; n = 9), patients who were responsive to rHuEPO (EPO-R; n = 9), and healthy control subjects (n = 9) [34].
  • We studied responses to the administration of two hypothalamic hormones, GHRH and ovine corticotropin-releasing hormone (CRH), in five anemic male patients on chronic hemodialysis before and after correction of the anemia with rHu-EPO [37].

Analytical, diagnostic and therapeutic context of Renal Dialysis


  1. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu, O., Feldman, J., Friedman, E.A. N. Engl. J. Med. (1996) [Pubmed]
  2. Effect of the dialysis membrane in the treatment of patients with acute renal failure. Hakim, R.M., Wingard, R.L., Parker, R.A. N. Engl. J. Med. (1994) [Pubmed]
  3. Conjugated estrogens for the management of bleeding associated with renal failure. Livio, M., Mannucci, P.M., Viganò, G., Mingardi, G., Lombardi, R., Mecca, G., Remuzzi, G. N. Engl. J. Med. (1986) [Pubmed]
  4. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. Goldberg, A.P., Applebaum-Bowden, D.M., Bierman, E.L., Hazzard, W.R., Haas, L.B., Sherrard, D.J., Brunzell, J.D., Huttunen, J.K., Ehnholm, C., Nikkila, E.A. N. Engl. J. Med. (1979) [Pubmed]
  5. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. Arnaout, M.A., Hakim, R.M., Todd, R.F., Dana, N., Colten, H.R. N. Engl. J. Med. (1985) [Pubmed]
  6. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk--The Study of Osteoporotic Fractures. Cauley, J.A., Zmuda, J.M., Yaffe, K., Kuller, L.H., Ferrell, R.E., Wisniewski, S.R., Cummings, S.R. J. Bone Miner. Res. (1999) [Pubmed]
  7. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity. Sprague, S.M., Corwin, H.L., Wilson, R.S., Mayor, G.H., Tanner, C.M. Arch. Intern. Med. (1986) [Pubmed]
  8. Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Ifudu, O., Paul, H., Mayers, J.D., Cohen, L.S., Brezsnyak, W.F., Herman, A.I., Avram, M.M., Friedman, E.A. Am. J. Kidney Dis. (1994) [Pubmed]
  9. Calcification of the epididymis and the tunica albuginea of the corpora cavernosa in patients on maintenance hemodialysis. Guvel, S., Pourbagher, M.A., Torun, D., Egilmez, T., Pourbagher, A., Ozkardes, H. J. Androl. (2004) [Pubmed]
  10. An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy. Janzen, L., Rich, J.A., Vercaigne, L.M. The Annals of pharmacotherapy. (1999) [Pubmed]
  11. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. Grohskopf, L.A., Roth, V.R., Feikin, D.R., Arduino, M.J., Carson, L.A., Tokars, J.I., Holt, S.C., Jensen, B.J., Hoffman, R.E., Jarvis, W.R. N. Engl. J. Med. (2001) [Pubmed]
  12. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. Hanly, P.J., Pierratos, A. N. Engl. J. Med. (2001) [Pubmed]
  13. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. Brent, J., McMartin, K., Phillips, S., Burkhart, K.K., Donovan, J.W., Wells, M., Kulig, K. N. Engl. J. Med. (1999) [Pubmed]
  14. Levonorgestrel-releasing intrauterine device for the treatment of menometrorrhagia in a woman on hemodialysis. Fedele, L., Gammaro, L., Bianchi, S. N. Engl. J. Med. (1999) [Pubmed]
  15. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. Dieplinger, H., Schoenfeld, P.Y., Fielding, C.J. J. Clin. Invest. (1986) [Pubmed]
  16. Standardized hemodialysis prescriptions promote inadequate treatment in patients with large body mass. Ifudu, O., Mayers, J.D., Matthew, J.J., Fowler, A.M., Homel, P., Friedman, E.A. Ann. Intern. Med. (1998) [Pubmed]
  17. Nosocomial transmission of delta hepatitis. Lettau, L.A., Alfred, H.J., Glew, R.H., Fields, H.A., Alter, M.J., Meyer, R., Hadler, S.C., Maynard, J.E. Ann. Intern. Med. (1986) [Pubmed]
  18. Renal transplantation in multiple myeloma. A case report. Humphrey, R.L., Wright, J.R., Zachary, J.B., Sterioff, S., DeFronzo, R.A. Ann. Intern. Med. (1975) [Pubmed]
  19. Propranolol, epinephrine, and accelerated hypertension during hemodialysis. Whelan, T.V. Ann. Intern. Med. (1987) [Pubmed]
  20. Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. Peterson, C.D., Collins, A.J., Himes, J.M., Bullock, M.L., Keane, W.F. N. Engl. J. Med. (1981) [Pubmed]
  21. Generation of dimethylnitrosamine in water purification systems. Detection in human blood samples during hemodialysis. Simenhoff, M.L., Dunn, S.R., Fiddler, W., Pensabene, J.W., Smiley, J. JAMA (1983) [Pubmed]
  22. X region deletion mutants associated with surface antigen-positive hepatitis B virus infections. Feitelson, M.A., Duan, L.X., Guo, J., Blumberg, B.S. Gastroenterology (1995) [Pubmed]
  23. Increased nitric oxide production in patients with hypotension during hemodialysis. Yokokawa, K., Mankus, R., Saklayen, M.G., Kohno, M., Yasunari, K., Minami, M., Kano, H., Horio, T., Takeda, T., Mandel, A.K. Ann. Intern. Med. (1995) [Pubmed]
  24. Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis. Altmann, P., Al-Salihi, F., Butter, K., Cutler, P., Blair, J., Leeming, R., Cunningham, J., Marsh, F. N. Engl. J. Med. (1987) [Pubmed]
  25. Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrine, and glucocorticoids. Mac Gregor, R.R. Ann. Intern. Med. (1977) [Pubmed]
  26. Neutrophil adhesiveness during prostacyclin and heparin hemodialysis. Spagnuolo, P.J., Bass, S.H., Smith, M.C., Danviriyasup, K., Dunn, M.J. Blood (1982) [Pubmed]
  27. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage. Oldfield, E.H., Clark, W.C., Dedrick, R.L., Egorin, M.J., Austin, H.A., DeVroom, H.D., Joyce, K.M., Doppman, J.L. Cancer Res. (1987) [Pubmed]
  28. Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Tomiya, T., Nagoshi, S., Fujiwara, K. Hepatology (1992) [Pubmed]
  29. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. Zusman, R.M., Rubin, R.H., Cato, A.E., Cocchetto, D.M., Crow, J.W., Tolkoff-Rubin, N. N. Engl. J. Med. (1981) [Pubmed]
  30. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. Owen, W.F., Lew, N.L., Liu, Y., Lowrie, E.G., Lazarus, J.M. N. Engl. J. Med. (1993) [Pubmed]
  31. Advanced glycosylation end products in patients with diabetic nephropathy. Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A., Vlassara, H. N. Engl. J. Med. (1991) [Pubmed]
  32. Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. Rapoport, J., Aviram, M., Chaimovitz, C., Brook, J.G. N. Engl. J. Med. (1978) [Pubmed]
  33. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. Pinnick, R.V., Wiegmann, T.B., Diederich, D.A. N. Engl. J. Med. (1983) [Pubmed]
  34. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. Akagi, S., Ichikawa, H., Okada, T., Sarai, A., Sugimoto, T., Morimoto, H., Kihara, T., Yano, A., Nakao, K., Nagake, Y., Wada, J., Makino, H. J. Am. Soc. Nephrol. (2004) [Pubmed]
  35. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. Segarra, A., Chacón, P., Martinez-Eyarre, C., Argelaguer, X., Vila, J., Ruiz, P., Fort, J., Bartolomé, J., Camps, J., Moliner, E., Pelegrí, A., Marco, F., Olmos, A., Piera, L. J. Am. Soc. Nephrol. (2001) [Pubmed]
  36. Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes. Sundaram, S., King, A.J., Pereira, B.J. J. Am. Soc. Nephrol. (1997) [Pubmed]
  37. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin. Ramirez, G., Bittle, P.A., Sanders, H., Rabb, H.A., Bercu, B.B. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
  38. Is blood urea nitrogen as good a guide for hemofiltration as for hemodialysis? De Fremont, J.F., Coevoet, B., Dkhissi, H., Pruna, A., Moriniere, P., Galy, C., Fournier, A. N. Engl. J. Med. (1982) [Pubmed]
  39. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. Rao, D.S., Shih, M.S., Mohini, R. N. Engl. J. Med. (1993) [Pubmed]
  40. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. Vincenti, F., Hattner, R., Amend, W.J., Feduska, N.J., Duca, R.M., Salvatierra, O. JAMA (1981) [Pubmed]
  41. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Yasuda, K., Okuda, K., Endo, N., Ishiwatari, Y., Ikeda, R., Hayashi, H., Yokozeki, K., Kobayashi, S., Irie, Y. Gastroenterology (1995) [Pubmed]
WikiGenes - Universities